about
P185
Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in ZambiaHow to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South AfricaThe cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes.Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.Improvements in physical wellbeing over the first two years on antiretroviral therapy in western KenyaAntiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya.Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South AfricaEarly loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South AfricaPEPFAR's support for orphans and vulnerable children: some beneficial effects, but too little data, and programs spread thin.Costs and cost-effectiveness of a mobile phone text-message reminder programmes to improve health workers' adherence to malaria guidelines in Kenya.Finding a needle in the haystack: the costs and cost-effectiveness of syphilis diagnosis and treatment during pregnancy to prevent congenital syphilis in Kalomo District of ZambiaRetention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysisDelays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis.Thresholds for the cost-effectiveness of interventions: alternative approaches.Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort studyHow much does it cost to improve access to voluntary medical male circumcision among high-risk, low-income communities in Uganda?The economic consequences of selected maternal and early childhood nutrition interventions in low- and middle-income countries: a review of the literature, 2000-2013.How to calculate the annual costs of NGO-implemented programmes to support orphans and vulnerable children: a six-step approach.Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South AfricaDesigning an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South AfricaART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South AfricaEffects of revised diagnostic recommendations on malaria treatment practices across age groups in KenyaDefining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa.HIV treatment produces economic returns through increased work and education, and warrants continued US supportSame-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not EnoughAccelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research AgendaA framework for evaluating the costs of malaria elimination interventions: an application to reactive case detection in Southern Province of Zambia, 2014.Calculating disability-adjusted-life-years lost (DALYs) in discrete-timeEffect of antiretroviral therapy on patients' economic well being: five-year follow-up.Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia.Exploring impacts of multi-year, community-based care programs for orphans and vulnerable children: a case study from Kenya.Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation.Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case.Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workersThe Enhanced Mentor Mother ProgrAm (EMMA) for the prevention of mother-to-child transmission of HIV in Kenya: study protocol for a cluster randomized controlled trial
P50
Q28535891-EB24CEC5-1F52-41B0-A38A-A44615FD5E90Q28730481-BF822EDF-649E-4014-8975-1CF72CA2E0B6Q33267919-789BE879-EF80-4210-81BC-81957C3CD0EBQ33482523-FCECFA68-18E2-4C57-B9CC-1E4497ED404FQ33697770-BDEAB35E-67C5-4CAF-BB14-C3B946221400Q33795359-08D0C670-A683-4C30-BC30-4BED2BC60CC4Q33831891-0C2C8C96-3ED5-4BDA-BC5E-4F066CC70503Q34092731-87AFEDFD-6B9C-4B65-88AA-E2FFA70E5CB7Q34196503-C2B1E10C-DCEB-4574-BA69-DDBC4FF6C623Q34331857-D59CDB4F-8704-4E8C-B842-5872D8A7E012Q34525926-10CE28B8-754C-410E-810C-37DF49C88843Q34639615-1BC1BCDB-89EA-45C4-9DBB-29E20A06BAD5Q34808183-1FF40AEB-B50E-4757-AE48-8610C906A3A6Q35066043-B6A05326-6E67-403C-8254-B5D5295DA34EQ35119997-E414CE89-1384-4F24-A3F2-0084661B361BQ35135593-D16D607A-54C4-451E-A27E-1D278DF0DBB4Q35180958-BC339E81-FB6E-4757-A50C-C2224933C7A0Q35532361-50F7637E-6ECB-4B92-8675-879BECA6AB94Q35735878-10072950-29F3-4560-A2C9-87B85BE54CF4Q36070803-CBA2FA69-05E7-4CB8-AFED-CF2175A9DAB8Q36265694-81739ADF-760A-4F1A-B6E5-346DC267D66CQ36279351-B1DF193B-BD1A-4EF1-BBE2-A00F3F05DAF9Q36508287-C95D64E4-9225-4173-8335-A132C241E84EQ36691692-6A30F4C1-E2C6-4AF9-87DA-FAAF9DE65F3DQ36992525-BF557948-8F3D-4A5C-A360-1098ED65D3E8Q37053825-0BD296B8-DCAC-4FE5-9804-D8ACEC7E3646Q37057563-15E6949E-4A40-44D8-AED3-4763F98FE978Q37061972-1B7DAC36-A5FA-4ABA-B834-B37D3123CC7CQ37162105-FF0A4C49-F3A0-4C2F-8E62-2CEB4088693FQ37170166-F540E6AA-02F4-4828-814A-F7F89EA29B1BQ37180851-1C79128E-67EB-4F7E-9031-A76162399C07Q37484444-0918BF90-E06E-4BB4-9CB1-CC37635BC09EQ37664377-A34A84CB-DB4D-41AA-A092-85CE2B01C25FQ37730306-1D025E84-ABEF-44C2-91BE-EEA180F70011Q39106516-A9376B5A-9732-428D-B1A0-E956F4F4F9A7Q39134436-C047220C-28C1-4593-9D95-EB6101F5FE24Q39336810-522ACFEF-785B-463F-B6CC-4C6A1521D8F1Q44032580-018C63F2-DD76-4C7D-947E-79E7F985E982Q57951998-10BD2AB5-5439-4400-AC51-8E7B00872B5FQ58099497-5A46539C-087F-4621-A2D5-C522CCD0A629
P50
description
agricultural economist
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruce A Larson
@ast
Bruce A Larson
@nl
Bruce A Larson
@sl
Bruce A. Larson
@en
Bruce A. Larson
@es
type
label
Bruce A Larson
@ast
Bruce A Larson
@nl
Bruce A Larson
@sl
Bruce A. Larson
@en
Bruce A. Larson
@es
altLabel
Bruce Alan Larson
@en
Bruce Larson
@en
prefLabel
Bruce A Larson
@ast
Bruce A Larson
@nl
Bruce A Larson
@sl
Bruce A. Larson
@en
Bruce A. Larson
@es
P1015
P214
P227
P244
P268
P269
P1015
P184
P1960
ThyJsz4AAAAJ
P21
P213
0000 0000 7998 2019
P214
P227
P244
P268
P269
P31
P496
0000-0002-9322-2387
P549
P569
1959-09-27T00:00:00Z